Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure
YazarOmaygenç, Mehmet Onur
Karaca, İbrahim Oğuz
Güneş, Hacı Murat
Üst veriTüm öğe kaydını göster
KünyeOmaygenç, M. O., Karaca, İ. O., Güler, E., Kızılırmak, F., Çakal, B., Güneş, H. M. ve Kılıçaslan, F. (2015). Radiofrequency catheter ablation of supraventricular tachycardia in pregnancy: Ablation without fluoroscopic exposure. Heart Rhythm, 12(5), 1057-1061. https://dx.doi.org/10.1016/j.hrthm.2015.01.037
Treatment of supraventricular tachycardia (SVT) during pregnancy can be troublesome. Antiarrhythmic drugs (especially beta-blockers and calcium channel blockers) are frequently used for treatment of symptomatic patients. However, routine and long-term use of these drugs is not recommended because most of them are classified as categories C and D by the US Food and Drug Administration.